Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1969 1
1971 1
1972 1
1973 3
1974 2
1975 4
1976 3
1977 4
1978 2
1979 2
1980 2
1981 7
1982 8
1983 7
1984 3
1985 4
1986 6
1987 5
1988 4
1989 7
1990 7
1991 8
1992 10
1993 7
1994 12
1995 15
1996 9
1997 9
1998 12
1999 13
2000 13
2001 13
2002 16
2003 17
2004 8
2005 8
2006 8
2007 11
2008 17
2009 17
2010 22
2011 18
2012 26
2013 31
2014 36
2015 65
2016 80
2017 67
2018 55
2019 36
2020 47
2021 52
2022 45
2023 65
2024 54
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

964 results

Results by year

Filters applied: . Clear all
Page 1
Intravascular Large B-cell Lymphoma in a Nasal Polyp.
Matsuda I, Kono H, Yoshihara K, Hirota S. Matsuda I, et al. Among authors: yoshihara k. Intern Med. 2025 Apr 12. doi: 10.2169/internalmedicine.4642-24. Online ahead of print. Intern Med. 2025. PMID: 40222925 Free article. No abstract available.
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort.
Shimomura T, Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, Mori K, Tashiro K, Katsumi K, Takahashi H, Yoshihara K, Miyajima K, Imai Y, Iwatani K, Kayano S, Igarashi T, Murakami M, Tsuzuki S, Yamada H, Miki J, Kimura T; JIKEI YAYOI Collaborative Group. Shimomura T, et al. Among authors: yoshihara k. Prostate. 2025 Apr 8. doi: 10.1002/pros.24898. Online ahead of print. Prostate. 2025. PMID: 40200561
PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Real-World Analyses?
Shimomura T, Otsuka N, Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, Mori K, Tashiro K, Katsumi K, Takahashi H, Yoshihara K, Miyajima K, Imai Y, Iwatani K, Kayano S, Igarashi T, Murakami M, Tsuzuki S, Yamada H, Miki J, Kimura T; JIKEI YAYOI Collaborative Group. Shimomura T, et al. Among authors: yoshihara k. Prostate. 2025 Apr 6. doi: 10.1002/pros.24885. Online ahead of print. Prostate. 2025. PMID: 40188390
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.
Tate S, Seki T, Nishikimi K, Unno Y, Itoi M, Ikeda S, Yoshikawa N, Akashi H, Suzuki E, Tanaka N, Hirakawa T, Kajiyama H, Takano H, Yoshihara K, Koga K, Okamoto A, Shozu M. Tate S, et al. Among authors: yoshihara k. J Gynecol Oncol. 2025 Mar 10. doi: 10.3802/jgo.2025.36.e80. Online ahead of print. J Gynecol Oncol. 2025. PMID: 40150913 Free article.
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant.
Ikeda S, Hasegawa K, Kogue Y, Arimori T, Kawamoto R, Wibowo T, Yaga M, Inada Y, Uehara H, Matsubara M, Tachikawa M, Suga M, Kida S, Shibata K, Tsutsumi K, Fukushima K, Fujita J, Ueda T, Kusakabe S, Hino A, Ichii M, Hirose A, Nakamae H, Hino M, Nakao T, Inoue M, Yoshihara K, Yoshihara S, Ueda S, Tachi T, Kuroda H, Murakami K, Kijima N, Kishima H, Igashira E, Murakami M, Takiuchi T, Kimura T, Hiroshima T, Kimura T, Shintani Y, Imai C, Yusa K, Mori R, Ogino T, Eguchi H, Takeda K, Oji Y, Kumanogoh A, Takagi J, Hosen N. Ikeda S, et al. Among authors: yoshihara k. Nat Cancer. 2025 Apr;6(4):595-611. doi: 10.1038/s43018-025-00934-1. Epub 2025 Mar 24. Nat Cancer. 2025. PMID: 40128569
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.
Kinoshita F, Tanzawa S, Misumi T, Yoshioka H, Miyauchi E, Ninomiya K, Murata Y, Takeshita M, Yamaguchi M, Sugawara S, Kawashima Y, Hashimoto K, Mori M, Miyanaga A, Hayashi A, Tanaka H, Honda R, Nojiri M, Sato Y, Yamamoto K, Masuda K, Kozuki T, Kawamura T, Suzuki T, Yamaguchi T, Asada K, Tetsumoto S, Tanaka H, Watanabe S, Umeda Y, Yamaguchi K, Kuyama S, Tsuruno K, Misumi Y, Kuraishi H, Yoshihara K, Nakao A, Kubo A, Yokoyama T, Watanabe K, Seki N. Kinoshita F, et al. Among authors: yoshihara k. Ther Adv Med Oncol. 2025 Mar 15;17:17588359241312503. doi: 10.1177/17588359241312503. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40093977 Free PMC article.
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Shibata K, Iwatani K, Imai YU, Yoshihara K, Miyajima K, Fukuokaya W, Ito K, Igarashi T, Yanagisawa T, Tashiro K, Tsuzuki S, Yuen SKK, Teoh JY, Yanada BA, Koike Y, Shimomura T, Yamada H, Furuta A, Miki J, Kimura T, Urabe F; JIKEI-YAYOI Collaborative Group. Shibata K, et al. Among authors: yoshihara k. In Vivo. 2025 Mar-Apr;39(2):824-833. doi: 10.21873/invivo.13885. In Vivo. 2025. PMID: 40010955 Free PMC article.
964 results